Robert J. Toth's most recent trade in TuHURA Biosciences Inc. was a trade of 100,000 Options (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TuHURA Biosciences Inc. | Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | Robert J. Toth | Director | 29 Apr 2021 | 1,300 | 0 | - | - | Series B Convertible Preferred Stock | ||
| TuHURA Biosciences Inc. | Robert J. Toth | Director | 29 Apr 2021 | 325 | 1,566 (0%) | 0% | - | Common Stock | ||
| TuHURA Biosciences Inc. | Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 29 Apr 2021 | 3 | 1,241 (0%) | 0% | 0 | Common Stock | |
| TuHURA Biosciences Inc. | Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 31 Mar 2021 | 8 | 1,238 (0%) | 0% | 0 | Common Stock | |
| TuHURA Biosciences Inc. | Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 30 Sep 2020 | 8 | 1,222 (0%) | 0% | 0 | Common Stock | |
| TuHURA Biosciences Inc. | Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) |